Tuesday, September 21, 2021
- Advertisement -spot_img


Dr. Reddy'

Dr Reddy’s reports 30% dip in net profit in Q2 year-on-year

On 22 October, the company experienced an information security incident and consequently isolated the impacted IT services. This incident involved a ransom-ware attack.

Dr Reddy’s joins global initiative to reduce carbon emissions

Hyderabad firm becomes the first Indian and the third Asian pharmaceutical company to have set its Science-Based Targets to further minimise environmental impact

Dr Reddy’s, Celgene settle Revlimid Capsules patent litigation

“We are pleased with the settlement agreement, and look forward to bringing a generic version of lenalidomide to market soon subject to regulatory approval for the benefit of patients.”

Dr Reddy’s launches Redyx for treatment of Covid-19 patients

Remdesivir is approved by Drug Controller General of India (DCGI) for restricted emergency use in India for the treatment of Covid-19 patients hospitalised with severe symptoms. Redyx is available in a strength of 100 mg vial.

SR University appoints Dr. G R C Reddy as Vice-Chancellor

Commenting on his appointment, Dr. Reddy said, “SRU ranks among the top 160 institutions in India and 5th in Telangana as per NIRF-MHRD. 

Dr Reddy’s inks pact with Gilead to manufacture Remdesivir

As per the non-exclusive licensing agreement, Gilead will grant the Hyderabad-based drug maker the right to register and manufacture its investigational drug Remdesivir in 127 countries, Dr Reddy's Laboratories said in a statement.

New head for Kakatiya University Geology Department

Warangal Urban: Dr R Mallikarjuna Reddy took charge as Head of the Department of Geology, Kakatiya University (KU) on Monday. His appointment order was...

Equity indices fall by 2.6 pc as US oil prices dip below zero dollar a barrel

Mumbai: Equity benchmark indices slipped by 2.7 per cent during early hours on Tuesday in line with Asian peers after US oil prices slipped...

‘Corona vaccine will be ready in 16 months’

Early detection is the key to control Covid-19, says Chairman of Asian Institurte of Gastroenterology

Dr Reddy’s to acquire select divisions of Wockhardt for Rs 1,850 cr

G V Prasad, the co-chairman and managing director of Dr Reddy’s said, “India is an important market for us and this acquisition will help in considerably scaling-up our domestic business."

Dr Reddy’s profit more than doubles to Rs 1,093 cr in Q2

Commenting on the financial results, Dr Reddy’s co-chairman and managing director, GV Prasad said "I am pleased with our performance across the businesses and strong cash generation during the quarter. We are progressing well in execution of our strategy and in our transformation journey on quality and efficiency."

Dr Reddy’s launches generic oral anti-epileptic drug

The product is a generic version of Lundbeck's Sabril powder for oral solution, Dr Reddy's said in a filing to the BSE

Dr Reddy’s expects FDA inspection of AP plant by year end

The USFDA had issued warning letter in November 2015 relating to Current Good Manufacturing Practice (CGMP) deviations at DR Reddy's API manufacturing facilities at Srikakulam in AP and Miryalaguda in Telangana besides its oncology formulation facility at Duvvada, Visakhapatnam

Nifty crosses 11,690 mark, Yes Bank gains over 2 pc

Among stocks, UPL gained 2.7 per cent while Yes Bank continued its upward slide by 2.3 per cent. Zee Entertainment, Kotak Mahindra Bank and Tech Mahindra also traded in the green.

Sensex, Nifty open higher tracking positive global cues

The gains were more pronounced in metal and pharma stocks. All sectoral indices except for Nifty IT were in the green at the National Stock Exchange.

Price erosion continues due to drug sellers consolidation in US: Dr Reddy’s

The Indian drug maker in a regulatory filing said its top ten customers in the USA account for approximately 77 per cent of the revenues from North America Global Generics

Dr Reddy’s launches Daptomycin in US

Dr Reddy’s Daptomycin for injection is available in single-dose 15 ml vials containing 500 mg of Daptomycin

Dutch journal honours IICT scientist

Hyderabad: International journal 'Molecular Catalysis', published by Dutch information and analytics company Elsevier Science, has come out with a special issue 'Metal Oxides in...

US court imposes $ 5 mn penalty on Dr Reddy’s over drug packaging

The court in New Jersey imposed the fine after a complaint that Dr Reddy Laboratories (DRL) failed to comply with the Poison Prevention Packaging Act (PPPA) and the Consumer Product Safety Act (CPSA).

Dr. Reddy’s in Guinness Book of Records

Hyderabad: A team of employees from Dr. Reddy’s Laboratories have set a Guinness World Record by creating the world’s largest cardboard mosaic that is...

Latest news

- Advertisement -spot_img
Telangana Today